Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ASP Isotopes Inc.ASPI · Entity 5371 | Director | October 26, 2023 | October 30, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ASP Isotopes Inc.
Report date October 26, 2023 · Filed October 30, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,104,167 |
Reported balance
After 2023-10-26 transaction · row 1
1 source rowRow 1 · 2023-10-26 · Purchase · Acquired 104,167 · Balance 1,104,167 F1: Shares of the Issuer's Common Stock were purchased in the Issuer's private placement of Common pursuant to a Securities Purchase Agreement, dated October 9, 2023, by and among the Issuer and the other purchasers named therein. The shares of Common Stock acquired were purchased at a price per share of $0.96 per share of Common Stock (the consolidated closing bid price per share immediately preceding the signing of the binding agreement to issue the securities). |
Filing footnotes · ownership attribution and instrument terms
F1: Shares of the Issuer's Common Stock were purchased in the Issuer's private placement of Common pursuant to a Securities Purchase Agreement, dated October 9, 2023, by and among the Issuer and the other purchasers named therein. The shares of Common Stock acquired were purchased at a price per share of $0.96 per share of Common Stock (the consolidated closing bid price per share immediately preceding the signing of the binding agreement to issue the securities).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 26, 2023 Filed Oct 30, 2023 21:50 UTC | ASP Isotopes Inc. ASPI · Entity 5371 | PurchaseCommon Stock | 104,167 | $0.96 | $100,000.32 |
DisclosureSEC source: 0001477932-23-007982 · form4.xml · nonDerivative · entry 1 Donfeld Joshua Jay · CIK 0001870347 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,104,167 F1 · deemedExecutionDate: Shares of the Issuer's Common Stock were purchased in the Issuer's private placement of Common pursuant to a Securities Purchase Agreement, dated October 9, 2023, by and among the Issuer and the other purchasers named therein. The shares of Common Stock acquired were purchased at a price per share of $0.96 per share of Common Stock (the consolidated closing bid price per share immediately preceding the signing of the binding agreement to issue the securities). Read SEC document |
| November 15, 2022 Filed Nov 16, 2022 12:38 UTC | ASP Isotopes Inc. ASPI · Entity 5371 | GrantCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-073089 · ownership.xml · nonDerivative · entry 1 Donfeld Joshua Jay · CIK 0001870347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000,000 F1 · deemedExecutionDate: This special one-time equity award of 200,000 restricted shares was contingent upon the completion of our IPO. Mr. Donfeld will receive 100,000 restricted shares of our common stock on November 15, 2023 and 100,000 restricted shares of our common stock on November 15, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.